NEWS

Latest News & Press

September 8, 2026

Canopy Growth Broadens Australian Medical Cannabis Portfolio with New Formats and Formulations

Canopy Growth Broadens Australia Medical Cannabis Portfolio with New Formats and Formulations

August 17, 2026

Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the Company has mailed

August 14, 2026

Poland drives Canopy’s international revenue

Every Canopy Growth business grew in Q1 FY27 - our CEO Luc Mongeau explains why on BNN Bloomberg.

August 14, 2026

Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows

Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Kincardine, Ontario cultivation facility (“Kincardine”) has received renewed European Union Good Manufacturing Practice

August 10, 2026

Canopy sees growing revenue, declining losses in Q1 2027

Canopy sees growing revenue, declining losses in Q1 2027 - Stratcann | August 7, 2026

August 7, 2026

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses

Canopy Growth Reports First Quarter Fiscal Year 2027 Financial Results; Delivers 13% Net Revenue Growth with Contributions from All Businesses
Scroll to Top